Shenzhen Shenxin Biotechnology Co., Ltd

This study tested a new mRNA vaccine called IN001 to see if it is safe and helps the body build immunity against shingles. It involved 150 healthy adults aged 50 to 69. Researchers monitored side effects and measured immune responses to find the best dose.